This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vanda Pharmaceuticals Inc (VNDA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 60.90M 64.76M 88.77M 87.92M
Receivables 3.65M 2.03M 1.17M 1.62M
Inventories 5.17M 0.00 57.00K 0.00
Other Current Assets 0.00 128.00K 0.00 0.00
Total Current Assets 141.73M 135.61M 125.97M 153.50M
Property, Plant & Equipment, Gross 4.17M 3.45M 3.17M 4.04M
Accumulated Depreciation & Depletion 1.73M 1.25M 818.00K 3.07M
Property, Plant & Equipment, Net 2.44M 2.20M 2.35M 964.00K
Intangibles 26.72M 5.04M 6.53M 8.03M
Other Non-Current Assets 813.00K 500.00K 600.00K 20.13M
Total Non-Current Assets 29.97M 7.74M 9.48M 29.12M
Liabilities & Shareholder Equity
Total Assets 171.70M 143.35M 135.45M 182.62M
Accounts Payable 835.00K 661.00K 287.00K 996.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 275.00K 221.00K 3.90M 0.00
Total Current Liabilities 7.79M 32.85M 32.26M 31.62M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 3.10M 2.89M 3.00M 461.00K
Other Non-Current Liabilities 0.00 63.49M 90.28M 117.06M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.10M 66.37M 93.28M 117.52M
Total Liabilities 10.89M 99.22M 125.54M 149.14M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 160.82M 44.12M 9.90M 33.47M
Common Par 41.00K 33.00K 28.00K 28.00K
Additional Paid In Capital 448.74M 355.43M 300.97M 296.87M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -287.98M -311.36M -291.11M -263.44M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 16.00K 21.00K 10.00K 21.00K
Total Capitalization 160.82M 44.12M 9.90M 33.47M
Total Equity 160.82M 44.12M 9.90M 33.47M
Total Liabilities & Stock Equity 171.70M 143.35M 135.45M 182.62M
Total Common Shares Outstanding 41.49M 33.34M 28.24M 28.12M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 34.77M 30.35M 28.23M 28.11M
Diluted Weighted Shares Outstanding 36.69M 30.35M 28.23M 28.11M
Number of Employees 64 53 40 38
Number of Part-Time Employees 0 0 0 0
VNDA News

VNDA Vanda Pharmaceuticals Inc

Chart of VNDA

Analysts Ratings for VNDA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VNDA ANALYST REPORT

Brokerage Partners

VNDA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs